BG
REGN icon

BDF Gestion’s Regeneron Pharmaceuticals REGN Stock Holding History

BDF Gestion’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Sell
1,524
-172
-10% -$117K 0.38% 68
2026
Q1 		$1.31M Hold
1,696
– – 0.18% 130
2025
Q4 		$1.31M Sell
1,696
-114
-6% -$77.4K 0.16% 129
2025
Q3 		$1.02M Sell
1,810
-379
-17% -$214K 0.12% 138
2025
Q2 		$1.15M Sell
2,189
-2,264
-51% -$1.26M 0.13% 130
2025
Q1 		$2.82M Hold
4,453
– – 0.31% 86
2024
Q4 		$3.17M Sell
4,453
-580
-12% -$487K 0.33% 75
2024
Q3 		$1.96M Buy
+5,033
New +$5.6M 0.21% 119

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BDF Gestion's REGN Position: Q2 2026 in Review

BDF Gestion reduced its Regeneron Pharmaceuticals (REGN) stake by 10% in Q2 2026, selling an estimated $117K and leaving 1,524 shares worth $2.8M. The position accounts for 0.38% of the portfolio, ranked #68.

BDF Gestion first reported a position in REGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.17M in Q4 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • BDF Gestion held 1,524 shares of Regeneron Pharmaceuticals worth $2.8M as of Q2 2026.
  • BDF Gestion sold 172 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $117K.
  • Regeneron Pharmaceuticals made up 0.38% of BDF Gestion's portfolio in Q2 2026, its #68 holding.
  • BDF Gestion first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • BDF Gestion's Regeneron Pharmaceuticals position peaked at $3.17M in Q4 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.